在日益扩大的先天性免疫缺陷的频谱中,HCT
Rafaella Muratori1, Carmem Bonfim2
1Hospital de Clínicas da Universidade Federal do Paraná.
Current opinion in hematology
|November 26, 2024
概括
造血干细胞移植 (HSCT) 对免疫的先天性错误 (IEI) 提供了有希望的结果. 对IEI的HSCT最近的进展,包括替代捐赠者和管理并发症,提供了有价值的临床见解.
科学领域:
- 免疫学 免疫学 免疫学
- 血液学 血液学 血液学
- 遗传学 是一个遗传学.
背景情况:
- 自1968年以来,造血干细胞移植 (HSCT) 已成为严重综合免疫缺陷 (SCID) 的基石治疗方法.
- 随着新基因和疾病的发现,先天性免疫错误 (IEI) 的范围继续扩大.
- 在HSCT技术的进步和对IEI的理解扩大了治疗指示和改善了治疗结果.
研究的目的:
- 审查血液细胞移植 (HCT) 的最新数据和进展,以治疗先天性免疫错误 (IEI).
- 为IEI强调与HCT相关的新型疾病和新出现的并发症.
- 综合当前的知识,用于临床实践,管理接受HCT的IEI患者.
主要方法:
- 对IEI的HCT最新科学文献和多中心研究的综述.
- 分析来自单一移植和新生儿查倡议的新兴数据.
- 对传染性并发症和长期并发症的洞察力的评估.
主要成果:
- 顺序相同的移植和新生儿查显示了IEI的有希望的结果.
- 免疫失调疾病需要仔细的移植前管理和潜在的额外疗法.
- 由于严重的表型,与X相关的慢性粒状瘤疾病的女性携带者可能需要HCT.
- 了解传染性并发症和并发症对于治疗决策至关重要.
结论:
- 针对免疫缺陷的造血细胞移植是一个快速发展的领域.
- 关于替代捐赠者移植的新数据和大型队列结果改善了临床实践.
- 长期并发症数据为管理IEI患者在HCT后提供了宝贵的知识.
相关概念视频
Bone Marrow Sampling and Transplants
284
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
284
Immunodeficiency Diseases
909
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
There are three main causes of immunodeficiency...
909
Regulation of Hematopoietic Stem Cells
3.1K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.1K
Tissue Transplantation
341
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
341
Stem Cell Therapy for Tissue Regeneration
4.0K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.0K
Multipotency of Hematopoietic Stem Cells
3.0K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.0K


